Abstract:Over recent years, many researchers have supported the autoimmune theory of sarcoidosis. The presence of uncontrolled inflammatory response on local and system levels in patients with sarcoidosis did not define that the immunoregulatory mechanisms could be affected. The aim of this study was to evaluate the distribution and the disturbance circulating Treg cell subsets in the peripheral blood in patients with sarcoidosis. Materials and methods: A prospective comparative study was performed in 2016–2018 (34 patients with sarcoidosis (men (67.6%), women (32.3%)) were examined). Healthy subjects—the control group (n = 40). The diagnosis of pulmonary sarcoidosis was performed according to the standard criteria. We used two ten-color combinations of antibodies for Treg immunophenotyping. The first one contained CD39–FITC, CD127–PE, CCR4–PE/DazzleTM 594, CD25–PC5.5, CD161–PC7, CD4–APC, CD8–APC–AF700, CD3–APC/Cy7, HLA–DR–PacBlue, and CD45 RA–BV 510TM, while the second consisted of CXCR3–Alexa Fluor 488, CD25–РЕ, CXCR5–РЕ/DazzleTM 594, CCR4–PerСP/Сy5.5, CCR6–РЕ/Cy7, CD4–АPC, CD8 АPC–AF700, CD3–АPC/Cy7, CCR7–BV 421, and CD45 RA–BV 510. The flow cytometry data were analyzed by using Kaluza software v2.3. A statistical analysis was performed with Statistica 7.0 and GraphPad Prism 8 software packages. Results of the study: Primarily, we found that patients with sarcoidosis had decreased absolute numbers of Treg cells in circulation. We noted that the level of CCR7-expressing Tregs decreased in patients with sarcoidosis vs. the control group (65.55% (60.08; 70.60) vs. 76.93% (69.59; 79.86) with p < 0.001). We noticed that the relative numbers of CD45RA–CCR7+ Tregs decreased in patients with sarcoidosis (27.11% vs. 35.43%, p < 0.001), while the frequency of CD45 RA–CCR7– and CD45RA+ CCR7– Tregs increased compared to the control group (33.3% vs. 22.73% and 0.76% vs. 0.51% with p < 0.001 and p = 0.028, respectively). CXCR3-expressing Treg cell subsets—Th1-like CCR60078CXCR3+ Tregs and Th17.1-like CCR6+ CXCR3+ Tregs—significantly increased in patients with sarcoidosis vs. the control group (14.4% vs. 10.5% with p < 0.01 and 27.9% vs. 22.8% with p < 0.01, respectively). Furthermore, the levels of peripheral blood EM Th17-like Tregs significantly decreased in the sarcoidosis group vs. the control group (36.38% vs. 46.70% with p < 0.001). Finally, we found that CXCR5 expression was increased in CM Tregs cell subsets in patients with sarcoidosis. Conclusions: Our data indicated a decrease in circulating Tregs absolute numbers and several alterations in Treg cell subsets. Moreover, our results highlight the presence of increased levels of CM CXCR5+ follicular Tregs in the periphery that could be linked with the imbalance of follicular Th cell subsets and alterations in B cell, based on the immune response. The balance between the two functionally distinct Treg cell populations—Th1-like and Th17-like Tregs—could be used in sarcoidosis diagnosis and the determination of prognosis and disease outcomes. Furthermore, we want to declare that analysis of Treg numbers of phenotypes could fully characterize their functional activity in peripherally inflamed tissues.

Serum amyloid A/anti-CCL20 induced the rebalance of Th17/regulatory T cells in SodA-induced sarcoidosis

Anti-TL1A Monoclonal Antibody Modulates the Dysregulation of Th1/Th17 Cells and Attenuates Granuloma Formation in Sarcoidosis by Inhibiting the PI3K/AKT Signaling Pathway

Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis

Dexamethasone Alleviates Pulmonary Sarcoidosis by Regulating the TGF-13/ Smad3 Signaling to Promote Th17/Treg Cell Rebalance

Dexamethasone Alleviates Pulmonary Sarcoidosis by Regulating the TGF-β/Smad3 Signaling to Promote Th17/Treg Cell Rebalance

Extensively Disturbance of Regulatory T Cells - Th17 Cells Balance in Stage II Pulmonary Sarcoidosis.

Serum amyloid A1 induced dysfunction of airway macrophages via CD36 pathway in allergic airway inflammation

Inhibition of Phosphoinositide‑3 Kinases Γ/δ Ameliorates Pulmonary Granuloma by Rescuing Treg Function in a Sarcoidosis Model.

Interleukin-17A plays a key role in pulmonary fibrosis following Propionibacterium acnes-induced sarcoidosis-like inflammation

Phosphoinositide 3‐kinase/protein Kinase B Inhibition Restores Regulatory T Cell's Function in Pulmonary Sarcoidosis

Elevated Expression of Serum Amyloid A 3 Protects Colon Epithelium Against Acute Injury Through TLR2-Dependent Induction of Neutrophil IL-22 Expression in a Mouse Model of Colitis

Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

FOXP3+ regulatory T cells are associated with the severity and prognosis of sarcoidosis

Circulating Regulatory T Cell Subsets in Patients with Sarcoidosis

Salvianolic Acid A Suppresses CCL-20 Expression in TNF-α–treated Macrophages and ApoE-deficient Mice

Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients

Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis

The Renin-Angiotensin-Aldosterone System Regulates Sarcoidosis Granulomatous Inflammation

Serum Amyloid A Induces M2 Macrophage-Specific Genes Expression and Promotes Efferocytosis of Apoptotic Neutrophils (P5072)

STAT3 and IL-6 Contribute to Corticosteroid Resistance in an OVA and Ozone-induced Asthma Model with Neutrophil Infiltration